ImageneBio (IMA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $4.04, +0.25% vs the prior close of $4.03.
- Volume 9.65K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
IMA ends flat (+0.2%) to $4.04. Closed at $4.04, +0.25% vs the prior close of $4.03. Day range $4.00–$4.15, opened at $4.15.
IMA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — IMA ends flat (+0.2%) to $4.04
- Closed at $4.04, +0.25% vs the prior close of $4.03. Day range $4.00–$4.15, opened at $4.15.
- Volume was 9.65K shares, 0.7x its 50-day average of 14.49K.
- Price is -19.1% vs its 50-day average ($5.00) and -29.9% vs its 200-day average ($5.76).
- 52-week range $3.90–$9.10; today's close sits at 3% of that range, 55.6% below the 52-week high.
Oct 15, 2026 — IMA dips 2.9% to $4.03, a 52-week low, 3 down days in a row
- Closed at $4.03, -2.91% vs the prior close of $4.15. Day range $3.98–$4.26, opened at $4.26.
- Volume was 21.60K shares, 1.5x its 50-day average of 14.21K.
- Price is -19.8% vs its 50-day average ($5.03) and -30.3% vs its 200-day average ($5.78).
- 52-week range $3.90–$9.10; today's close sits at 3% of that range, 55.7% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — IMA dips 2.1% to $4.15, a 52-week low
- Closed at $4.15, -2.10% vs the prior close of $4.24. Day range $4.14–$4.20, opened at $4.20.
- Volume was 20.80K shares, 1.5x its 50-day average of 13.94K.
- Price is -18.0% vs its 50-day average ($5.06) and -28.3% vs its 200-day average ($5.79).
- 52-week range $3.90–$9.10; today's close sits at 5% of that range, 54.4% below the 52-week high.
Oct 13, 2026 — IMA ends flat (-0.2%) to $4.24
- Closed at $4.24, -0.24% vs the prior close of $4.25. Day range $4.05–$4.25, opened at $4.16.
- Volume was 10.10K shares, 0.7x its 50-day average of 13.81K.
- Price is -16.7% vs its 50-day average ($5.09) and -26.9% vs its 200-day average ($5.80).
- 52-week range $3.90–$9.10; today's close sits at 7% of that range, 53.4% below the 52-week high.
Oct 12, 2026 — IMA ends flat (+0.2%) to $4.25 on 2.1x normal volume
- Closed at $4.25, +0.24% vs the prior close of $4.24. Day range $4.00–$4.29, opened at $4.29.
- Volume was 28.10K shares, 2.1x its 50-day average of 13.41K — unusually heavy trading.
- Price is -17.0% vs its 50-day average ($5.12) and -26.8% vs its 200-day average ($5.81).
- 52-week range $3.90–$9.10; today's close sits at 7% of that range, 53.3% below the 52-week high.
Oct 9, 2026 — IMA dips 0.5% to $4.24, a 52-week low
- Closed at $4.24, -0.47% vs the prior close of $4.26. Day range $3.90–$4.31, opened at $4.17.
- Volume was 8.10K shares, 0.6x its 50-day average of 13.34K.
- Price is -17.6% vs its 50-day average ($5.15) and -27.1% vs its 200-day average ($5.82).
- 52-week range $3.90–$9.10; today's close sits at 7% of that range, 53.4% below the 52-week high.
Oct 8, 2026 — IMA slides 7.6% to $4.26, a 52-week low on 2.3x normal volume
- Closed at $4.26, -7.59% vs the prior close of $4.61. Day range $4.00–$4.48, opened at $4.48.
- Volume was 30.10K shares, 2.3x its 50-day average of 13.25K — unusually heavy trading.
- Price is -17.8% vs its 50-day average ($5.18) and -26.9% vs its 200-day average ($5.83).
- 52-week range $3.94–$9.10; today's close sits at 6% of that range, 53.2% below the 52-week high.
Oct 7, 2026 — IMA ends flat (+0.2%) to $4.61
- Closed at $4.61, +0.22% vs the prior close of $4.60. Day range $4.60–$4.61, opened at $4.60.
- Volume was 2.20K shares, 0.2x its 50-day average of 13.28K — lighter than usual.
- Price is -11.4% vs its 50-day average ($5.21) and -21.0% vs its 200-day average ($5.83).
- 52-week range $3.94–$9.10; today's close sits at 13% of that range, 49.3% below the 52-week high.
Oct 6, 2026 — IMA dips 2.1% to $4.60
- Closed at $4.60, -2.13% vs the prior close of $4.70. Day range $4.60–$4.72, opened at $4.70.
- Volume was 13.70K shares, 1.0x its 50-day average of 13.24K.
- Price is -12.0% vs its 50-day average ($5.23) and -21.3% vs its 200-day average ($5.84).
- 52-week range $3.94–$9.10; today's close sits at 13% of that range, 49.5% below the 52-week high.
Oct 5, 2026 — IMA rises 2.2% to $4.70
- Closed at $4.70, +2.17% vs the prior close of $4.60. Day range $4.60–$4.73, opened at $4.60.
- Volume was 8.50K shares, 0.6x its 50-day average of 13.25K.
- Price is -10.5% vs its 50-day average ($5.25) and -19.7% vs its 200-day average ($5.85).
- 52-week range $3.94–$9.10; today's close sits at 15% of that range, 48.4% below the 52-week high.
Oct 2, 2026 — IMA rises 0.4% to $4.60
- Closed at $4.60, +0.44% vs the prior close of $4.58. Day range $4.56–$4.68, opened at $4.68.
- Volume was 7.80K shares, 0.6x its 50-day average of 13.24K — lighter than usual.
- Price is -12.7% vs its 50-day average ($5.27) and -21.5% vs its 200-day average ($5.86).
- 52-week range $3.94–$9.10; today's close sits at 13% of that range, 49.5% below the 52-week high.
IMA latest news & SEC filings
Every SEC filing by or about IMA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 11, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 5, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 5, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 5, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 5, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$10.18M (prior year -$7.58M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.63 (prior year -$4.46) (loss narrowed vs Jun 30, 2025)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 28, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jul 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade IMA
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 10, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.47% (largest 7.6%).
- Liquidity: about 12.34K shares (≈$49.84K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $4.04 vs a range of $3.90–$9.10 (3% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:12 on Jul 28, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 8 sales; latest: Robert B Lally sold 1,525 shares on Jul 17, 2026.
- Latest filings: 10-Q Aug 5, 2026; 8-K Aug 5, 2026; 8-K Jul 23, 2026.
- Share count: 11.35M shares outstanding (Jul 31, 2026), -76.5% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
IMA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 4.15 | 4.15 | 4.00 | 4.04 | 9.65K |
| Oct 15, 2026 | 4.26 | 4.26 | 3.98 | 4.03 | 21.60K |
| Oct 14, 2026 | 4.20 | 4.20 | 4.14 | 4.15 | 20.80K |
| Oct 13, 2026 | 4.16 | 4.25 | 4.05 | 4.24 | 10.10K |
| Oct 12, 2026 | 4.29 | 4.29 | 4.00 | 4.25 | 28.10K |
| Oct 9, 2026 | 4.17 | 4.31 | 3.90 | 4.24 | 8.10K |
| Oct 8, 2026 | 4.48 | 4.48 | 4.00 | 4.26 | 30.10K |
| Oct 7, 2026 | 4.60 | 4.61 | 4.60 | 4.61 | 2.20K |
| Oct 6, 2026 | 4.70 | 4.72 | 4.60 | 4.60 | 13.70K |
| Oct 5, 2026 | 4.60 | 4.73 | 4.60 | 4.70 | 8.50K |
| Oct 2, 2026 | 4.68 | 4.68 | 4.56 | 4.60 | 7.80K |
| Oct 1, 2026 | 4.60 | 4.67 | 4.58 | 4.58 | 11.80K |
| Sep 30, 2026 | 4.58 | 4.63 | 4.58 | 4.58 | 9.40K |
| Sep 29, 2026 | 4.61 | 4.61 | 4.57 | 4.58 | 7.30K |
| Sep 28, 2026 | 4.84 | 4.84 | 4.64 | 4.64 | 2.20K |
| Sep 25, 2026 | 4.70 | 4.81 | 4.70 | 4.72 | 17.80K |
| Sep 24, 2026 | 4.82 | 4.82 | 4.65 | 4.66 | 3.70K |
| Sep 23, 2026 | 4.95 | 4.97 | 4.81 | 4.84 | 1.50K |
| Sep 22, 2026 | 4.76 | 5.02 | 4.76 | 4.85 | 8.50K |
| Sep 21, 2026 | 4.80 | 5.10 | 4.80 | 4.81 | 23.90K |
About ImageneBio
ImageneBio (IMA) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in SAN DIEGO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1835579.
IMA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| David P Bonita | Director | Jun 18, 2026 |
| Advisors Llc Orbimed | Director | Apr 16, 2026 |
| Capital Gp Vi Llc Orbimed | Director | Apr 16, 2026 |
| Genesis Gp Llc Orbimed | Director | Apr 16, 2026 |
| Joseph P Slattery | Director | Jun 18, 2026 |
| Otello Stampacchia | Director | Jun 18, 2026 |
| Wei-Guo Su | Director | Apr 16, 2026 |
| Jonathan Jian Wang | Director | Jun 18, 2026 |
| Stephen Hui Wang | Director | Dec 22, 2025 |
| Kristin Yarema | Chief Executive Officer | Aug 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Erin Butler | Principal Accounting Officer | Jan 2, 2026 |
| Yanina Grant-Huerta | Chief Financial Officer | Aug 17, 2026 |
| Robert B Lally | Principal Accounting Officer | Jul 20, 2026 |
| Benjamin Porter-Brown | Chief Medical Officer | Feb 20, 2026 |
| Kristin Yarema | Chief Executive Officer | Aug 17, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 17, 2026 | Robert B Lally | Sale | 1,525 | $5.34 |
| Jul 17, 2026 | Robert B Lally | Sale | 1,525 | $5.34 |
| Jul 17, 2026 | Robert B Lally | Sale | 1,525 | $5.34 |
| Jul 17, 2026 | Robert B Lally | Sale | 1,525 | $5.34 |
| Jul 16, 2026 | Robert B Lally | Sale | 1,671 | $5.50 |
| Jul 16, 2026 | Robert B Lally | Sale | 1,671 | $5.50 |
| Jul 16, 2026 | Robert B Lally | Sale | 1,671 | $5.50 |
| Jul 16, 2026 | Robert B Lally | Sale | 1,671 | $5.50 |
| Dec 24, 2025 | Joseph P Slattery | Buy | 16,000 | $5.99 |
| Dec 24, 2025 | Joseph P Slattery | Buy | 16,000 | $5.99 |
| Dec 24, 2025 | Joseph P Slattery | Buy | 16,000 | $5.99 |
| Dec 24, 2025 | Joseph P Slattery | Buy | 16,000 | $5.99 |
IMA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $800.00K | $-45.35M | -9.64 | $-47.84M |
| Dec 31, 2024 | $3.50M | $-36.57M | -22.10 | $-21.32M |
| Dec 31, 2023 | $9.16M | $-68.17M | -1.63 | $-79.74M |
| Dec 31, 2022 | $15.62M | $-68.77M | -1.90 | $-74.11M |
| Dec 31, 2021 | $30.98M | $-34.12M | -1.22 | $-60.25M |
Latest balance sheet: total assets $152.04M, total liabilities $9.97M, cash $94.68M (as of Jun 30, 2026).
IMA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $5.75 |
| May 7, 2026 | 8-K Item 2.02 (results) | $5.91 |
| Mar 10, 2026 | 8-K Item 2.02 (results) | $6.07 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $8.55 |
| Jan 18, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
| Aug 12, 2021 | 8-K Item 2.02 (results) | — |
| May 13, 2021 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on IMA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.